Every Phisician who works with anticoagulantion should has this program on his pocket. Congratulations to the developers and to ACC for supporting this project.
Estimation application downloads and cost
Description
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patients renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
Read more
Use the app to:
• Calculate a patients renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
AnticoagEvaluator screenshorts
ASO analyse AnticoagEvaluator app for iPhone and iPad
No search terms founded
Competitors of AnticoagEvaluator application
Application availability
Available in countries
| Country | Price |
|---|---|
| Canada | free |
| China | free |
| France | free |
| Germany | free |
| Italy | free |
| Netherlands | free |
| Portugal | free |
| Spain | free |
| Poland | free |
| UK | free |
| India | free |
| Japan | free |
| Korea, Republic Of | free |
| Poland | free |
| Russia | free |
| Turkey | free |
| USA | free |
| Korea, Republic Of | free |
| Ukraine | free |
Available for devices
iPhone4, iPad2Wifi, iPad23G, iPhone4S, iPadThirdGen, iPadThirdGen4G, iPhone5, iPodTouchFifthGen, iPadFourthGen, iPadFourthGen4G, iPadMini, iPadMini4G, iPhone5c, iPhone5s, iPadAir, iPadAirCellular, iPadMiniRetina, iPadMiniRetinaCellular, iPhone6, iPhone6Plus, iPadAir2, iPadAir2Cellular, iPadMini3, iPadMini3Cellular, iPodTouchSixthGen, iPhone6s, iPhone6sPlus, iPadMini4, iPadMini4Cellular, iPadPro, iPadProCellular, iPadPro97, iPadPro97Cellular, iPhoneSE, iPhone7, iPhone7Plus, iPad611, iPad612, iPad71, iPad72, iPad73, iPad74, iPhone8, iPhone8Plus, iPhoneX, iPad75, iPad76, iPhoneXS, iPhoneXSMax, iPhoneXR, iPad812, iPad834, iPad856, iPad878, Watch4, iPadMini5, iPadMini5Cellular, iPadAir3, iPadAir3Cellular, iPodTouchSeventhGen, iPhone11, iPhone11Pro, Watch5, iPadSeventhGen, iPadSeventhGenCellular, iPhone11ProMax, iPhoneSESecondGen, iPadProSecondGen, iPadProSecondGenCellular, iPadProFourthGen, iPadProFourthGenCellular,Versions and releases
Latest version AnticoagEvaluator: 4.0
This update includes underlying architecture improvements and minor reference link updates.
Apps Changes History:
- 6 months ago: New App Version 3.0 ☛ 4.0
Reviews
Excellent Program
Super!
The best!
Great tool to estimate risk
Especially like how each therapy can be compared.
Ios7 update messed up the app
The new update that made this app ios7 compatible actually has a bug. The bar that is supposed to seperate the app display screen from top part of the screen where time and battery are displayed is actually at the bottom of the screen. Therefore all the results hide behind time and battery icon
Top of the screen
Agree with the first review Top email and risk summary are hidden behind battery and time
Current version fails
Ios8 version does not work
No conversion
Since iOS8 update app is useless as Im finding with a lot of apps post iOS8.
Other apps from American College of Cardiology
